SARS-CoV-2-IN-116 (Compound (S,S)-4) is a highly selective inhibitor of angiotensin-converting enzyme 2 (ACE2) with a pIC50 of 7.61. It prevents the binding of the SARS-CoV-2 spike protein to ACE2 and holds promise for research related to COVID-19.
Target-Kategorie:
Angiotensin-converting Enzyme (ACE)|||SARS-CoV
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten
